Insider Trading March 4, 2026

Saba Capital Reduces Stake in BlackRock ESG Term Trust with $3.7 Million Sale

Ten percent holder Saba sells 244,943 ECAT shares while retaining a 23.12 million-share position; fund yields 22.22% and trades just under the sale price

By Priya Menon ECAT
Saba Capital Reduces Stake in BlackRock ESG Term Trust with $3.7 Million Sale
ECAT

Saba Capital Management, L.P., a roughly 10% holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), reported a sale of 244,943 shares on March 2, 2026, according to a Form 4 filing. The block was executed at $15.15 per share for proceeds of $3,710,886. After the transaction Saba directly holds 23,123,608 shares. ECAT currently trades at $14.96, carries a 22.22% dividend yield and a market capitalization of $1.49 billion. InvestingPro Tips notes the fund has increased its dividend for five consecutive years and offers additional ProTips and metrics on its platform.

Key Points

  • Saba Capital Management, L.P. sold 244,943 shares of BlackRock ESG Capital Allocation Term Trust on March 2, 2026 for $15.15 per share, totaling $3,710,886.
  • After the sale Saba directly owns 23,123,608 shares; Saba was identified as a ten percent owner of ECAT.
  • ECAT is trading at $14.96, carries a 22.22% dividend yield and has a market capitalization of $1.49 billion. InvestingPro Tips reports the trust has raised its dividend for five consecutive years.

Saba Capital Management, L.P. disclosed a sale of 244,943 common shares of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT) on March 2, 2026, per a Form 4 filing with the Securities and Exchange Commission. The shares were sold at $15.15 apiece, producing proceeds of $3,710,886.

Following the disposition, Saba Capital Management, L.P. is recorded as directly owning 23,123,608 shares of ECAT. The filing identifies Saba as a ten percent owner of the trust prior to the sale.

At present the market quotes ECAT at $14.96, which is slightly below the sale price reported in the Form 4. The fund carries a reported dividend yield of 22.22% and a market capitalization of $1.49 billion.

Information drawn from InvestingPro Tips included in the filing notes that ECAT pays a substantial dividend to shareholders and that the trust has increased its dividend for five consecutive years. The InvestingPro Tips entry also indicates there are three additional ProTips and broader financial metrics available on the platform for investors who wish to review them.

This transaction records a partial reduction in Saba Capital's direct holdings in ECAT while leaving the firm as a large shareholder. The sale amount and per-share price are stated exactly as reported in the regulatory filing, and the current trading price, dividend yield and market capitalization reflect the values cited alongside the transaction details.


Contextual summary

The Form 4 filing documents a routine insider sale by a significant holder of an exchange-traded closed-end fund. The factual record shows the amount sold, the price per share, total proceeds, the remaining direct ownership position, and basic market metrics for the fund.


Market signal

The facts reported in the filing do not include commentary from the seller or the trust about motive or future intentions. They do, however, provide clear, quantifiable changes to ownership and furnish contemporaneous market metrics including price, yield and market capitalization.

Risks

  • The Form 4 shows a significant shareholder sale but does not include rationale, leaving uncertainty about the motivation or whether further selling may follow - this affects investor perception of the fund.
  • The current trading price of $14.96 is slightly below the sale price of $15.15, which may create short-term price volatility for ECAT shares as market participants digest the transaction.
  • Reliance on dividend yield metrics and historical payout increases may not reflect future distributions; the filing does not provide forward-looking dividend guidance.

More from Insider Trading

ChargePoint CRO Sells Small Stake as Company Posts Revenue Growth, Continued Losses Mar 23, 2026 ChargePoint General Counsel Sells $14,283 in Stock as Company Navigates Growth and Losses Mar 23, 2026 ChargePoint Executive Sells Small Stake to Cover Taxes as Company Posts Q4 Revenue Gain Mar 23, 2026 ChargePoint CFO Sells $12,248 in Shares as Stock Hovers Near 52-Week Low Mar 23, 2026 BCP Investment CIO Increases Stake with $19,852 Purchase as Shares Trade Near 52-Week Low Mar 23, 2026